title: Clinico-pathological and biomolecular findings in Italian patients with multiple cutaneous neurofibromas.
abstract: BACKGROUND
  Neurofibroma occurs as isolated or multiple lesions frequently associated with neurofibromatosis type 1 (NF1), a common autosomal dominant disorder affecting 1 in 3500 individuals. It is caused by mutations in the NF1 gene, which comprises 60 exons and is located on chromosome 17q11.2. NF1 is a fully penetrant gene exhibiting a mutation rate some 10-fold higher compared with most other disease genes. As a consequence, a high number of cases (up to 50%) are sporadic. Mutation detection is complex due to the large size of the NF1 gene, the presence of pseudogenes and the great variety of lesions.
  
  
  METHODS
  110 patients with at least two neurofibroma lesions recorded in the files of the Pathology Department of the University of Modena during the period 1999-2010, were included in this study. Through interviews and examination of clinical charts, pedigrees were drawn for all patients who were affected by at least two neurofibromas. We attempted to delineate the clinical features of NF1 and the mutational spectrum in the cohort of 11 NF1 families identified. For each proband, the whole coding sequence and all splice sites were studied for mutations, either by the protein truncation test (PTT), or, more frequently, by denaturing high performance liquid chromatography (DHPLC). Two GIST tumors of NF1 patients were tested for somatic NF1 mutations.
  
  
  RESULTS
  NF1 germline mutations were identified in 7 (68%) patients. A novel mutation, c.3457_3460delCTCA in exon 20, was detected in two unrelated patients and was associated with different clinical features. No NF1 somatic mutations were detected in the GIST tumors. A wide phenotypic and genotypic variability was registered, both in the spectrum of skin lesions and visceral neoplasms, even among members of the same family who had different clinical manifestations. A proclivity to multiple tumors arising in the same subject, and a higher tumor burden per family were the most relevant findings observed in patients affected with the NF1 mutation.
  
  
  CONCLUSIONS
  We report a novel NF1 mutation and we contribute data for the refinement of the NF1 genotype-phenotype spectrum.
authors.affiliation: Department of Internal Medicine, Division of Dermatology, University of Modena and Reggio Emilia, Modena, Italy. giovanni.ponti@unimore.it.
authors.forename: Giovanni
authors.initials: G
authors.lastname: Ponti
authors.forename: Lorena
authors.initials: L
authors.lastname: Losi
authors.forename: Davide
authors.initials: D
authors.lastname: Martorana
authors.forename: Manuela
authors.initials: M
authors.lastname: Priola
authors.forename: Elisa
authors.initials: E
authors.lastname: Boni
authors.forename: Annamaria
authors.initials: A
authors.lastname: Pollio
authors.forename: Tauro Maria
authors.initials: TM
authors.lastname: Neri
authors.forename: Stefania
authors.initials: S
authors.lastname: Seidenari